Literature DB >> 22539548

Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke.

Greg Zaharchuk1, Ibraheem S El Mogy, Nancy J Fischbein, Gregory W Albers.   

Abstract

BACKGROUND AND
PURPOSE: The perfusion-weighted imaging (PWI)-diffusion-weighted imaging (DWI) mismatch paradigm is widely used in stroke imaging studies. Arterial spin labeling (ASL) is an alternative perfusion method that does not require contrast. This study compares the agreement of ASL-DWI and PWI-DWI mismatch classification in patients with stroke.
METHODS: This was a retrospective study drawn from all 1.5-T MRI studies performed in 2010 at a single institution. Inclusion criteria were: symptom onset<5 days, DWI lesion>10 mL, and acquisition of both PWI and ASL. DWI and PWI time to maximum>6 seconds lesion volumes were determined using automated software. Patients were classified into reperfused, matched, or mismatch groups. Two radiologists classified ASL-DWI qualitatively into the same categories blinded to DWI-PWI. Agreement between both individual readers and methods was assessed.
RESULTS: Fifty-one studies met the inclusion criteria. Seven cases were excluded (1 due to PWI susceptibility artifact, 2 due to motion, and 4 due to severe ASL border zone sign), resulting in 44 studies for comparison. Interrater agreement for ASL-DWI mismatch status was high (κ=0.92; 95% CI, 0.80-1.00). ASL-DWI and PWI-DWI mismatch categories agreed in 25 of 44 cases (57%). In the 16 of 19 discrepant cases (84%), ASL overestimated the PWI lesion size. In 34 of 44 cases (77%), they agreed regarding the presence of mismatch versus no mismatch.
CONCLUSIONS: Mismatch classification based on ASL and PWI agrees frequently but not perfectly. ASL tends to overestimate the PWI time to maximum lesion volume. Improved ASL methodologies and/or higher field strength are necessary before ASL can be recommended for routine use in acute stroke.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539548      PMCID: PMC3383868          DOI: 10.1161/STROKEAHA.111.639773

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  32 in total

1.  Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements.

Authors:  Matthias Günther; Koichi Oshio; David A Feinberg
Journal:  Magn Reson Med       Date:  2005-08       Impact factor: 4.668

2.  Velocity-selective arterial spin labeling.

Authors:  Eric C Wong; Matthew Cronin; Wen-Chau Wu; Ben Inglis; Lawrence R Frank; Thomas T Liu
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

3.  Recurrence of stroke after cardiac surgery: insight into pathogenesis via diffusion-weighted and continuous arterial spin labeling perfusion magnetic resonance imaging.

Authors:  Thomas F Floyd; Frances Harris; Michael McGarvey; John A Detre
Journal:  J Cardiothorac Vasc Anesth       Date:  2006-04-05       Impact factor: 2.628

4.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.

Authors:  Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

5.  Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke.

Authors:  Gregory A Christoforidis; Yousef Mohammad; Dimitris Kehagias; Bindu Avutu; Andrew P Slivka
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

6.  Comparison of EPISTAR and T2*-weighted gadolinium-enhanced perfusion imaging in patients with acute cerebral ischemia.

Authors:  B Siewert; G Schlaug; R R Edelman; S Warach
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

7.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

8.  Internal carotid artery occlusion assessed at pulsed arterial spin-labeling perfusion MR imaging at multiple delay times.

Authors:  Jeroen Hendrikse; Matthias J P van Osch; Dirk R Rutgers; Chris J G Bakker; L Jaap Kappelle; Xavier Golay; Jeroen van der Grond
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

9.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

Authors:  Stephen M Davis; Geoffrey A Donnan; Mark W Parsons; Christopher Levi; Kenneth S Butcher; Andre Peeters; P Alan Barber; Christopher Bladin; Deidre A De Silva; Graham Byrnes; Jonathan B Chalk; John N Fink; Thomas E Kimber; David Schultz; Peter J Hand; Judith Frayne; Graeme Hankey; Keith Muir; Richard Gerraty; Brian M Tress; Patricia M Desmond
Journal:  Lancet Neurol       Date:  2008-02-28       Impact factor: 44.182

10.  Perfusion imaging.

Authors:  J A Detre; J S Leigh; D S Williams; A P Koretsky
Journal:  Magn Reson Med       Date:  1992-01       Impact factor: 4.668

View more
  26 in total

1.  Comparative study of DSC-PWI and 3D-ASL in ischemic stroke patients.

Authors:  Shui-Xia Zhang; Yi-Hao Yao; Shun Zhang; Wen-Jie Zhu; Xiang-Yu Tang; Yuan-Yuan Qin; Ling-Yun Zhao; Cheng-Xia Liu; Wen-Zhen Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

Review 2.  Arterial spin-labeled perfusion imaging in acute ischemic stroke.

Authors:  Greg Zaharchuk
Journal:  Stroke       Date:  2014-03-06       Impact factor: 7.914

3.  Monitoring cerebral blood flow change through use of arterial spin labelling in acute ischaemic stroke patients after intra-arterial thrombectomy.

Authors:  Roh-Eul Yoo; Tae Jin Yun; Dong Hyun Yoo; Young Dae Cho; Hyun-Seung Kang; Byung-Woo Yoon; Keun-Hwa Jung; Koung Mi Kang; Seung Hong Choi; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2018-02-23       Impact factor: 5.315

Review 4.  Recent progress in ASL.

Authors:  Luis Hernandez-Garcia; Anish Lahiri; Jonas Schollenberger
Journal:  Neuroimage       Date:  2018-01-03       Impact factor: 6.556

5.  Increased hippocampal blood volume and normal blood flow in schizophrenia.

Authors:  Pratik Talati; Swati Rane; Jack Skinner; John Gore; Stephan Heckers
Journal:  Psychiatry Res       Date:  2015-04-03       Impact factor: 3.222

6.  Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain.

Authors:  Jalal B Andre; Seema Nagpal; Daniel S Hippe; Ali C Ravanpay; Heiko Schmiedeskamp; Roland Bammer; Gerald J Palagallo; Lawrence Recht; Greg Zaharchuk
Journal:  Neuroradiol J       Date:  2015-04-28

7.  Arterial spin labeling imaging correlates with the angiographic and clinical vascularity of vestibular schwannomas.

Authors:  Yujiro Tanaka; Michihiro Kohno; Takao Hashimoto; Nobuyuki Nakajima; Hitoshi Izawa; Hirofumi Okada; Norio Ichimasu; Ken Matsushima; Tomoya Yokoyama
Journal:  Neuroradiology       Date:  2020-01-09       Impact factor: 2.804

8.  Arterial spin labeling for acute stroke: practical considerations.

Authors:  Greg Zaharchuk
Journal:  Transl Stroke Res       Date:  2012-04-14       Impact factor: 6.829

9.  Advances in stroke: Imaging 2013.

Authors:  Wolf-Dieter Heiss; Chelsea S Kidwell
Journal:  Stroke       Date:  2014-01-16       Impact factor: 7.914

10.  Quantitative analysis of hypoperfusion in acute stroke: arterial spin labeling versus dynamic susceptibility contrast.

Authors:  Kambiz Nael; Arash Meshksar; David S Liebeskind; Bruce M Coull; Elizabeth A Krupinski; J Pablo Villablanca
Journal:  Stroke       Date:  2013-08-29       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.